Characterisation & Predictive Value of the Human Cellular Immune Response to Chemoimmunotherapy with Cisplatin Pemetraxed & CD40 Activation

Project Details

StatusFinished
Effective start/end date1/01/1231/12/12

Funding

  • Cancer Council NSW: AUD89,983.00